GR80020B - Steroids useful as anti-cancer,anti-obesity,anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents - Google Patents

Steroids useful as anti-cancer,anti-obesity,anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents

Info

Publication number
GR80020B
GR80020B GR80020A GR840180020A GR80020B GR 80020 B GR80020 B GR 80020B GR 80020 A GR80020 A GR 80020A GR 840180020 A GR840180020 A GR 840180020A GR 80020 B GR80020 B GR 80020B
Authority
GR
Greece
Prior art keywords
hyperglycemic
obesity
autoimmune
cancer
hypercholesterolemic agents
Prior art date
Application number
GR80020A
Other languages
English (en)
Inventor
Schwartz G Arthur
Williams John
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of GR80020B publication Critical patent/GR80020B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/001—Lactones
    • C07J21/003—Lactones at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR80020A 1983-08-02 1984-08-02 Steroids useful as anti-cancer,anti-obesity,anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents GR80020B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51955083A 1983-08-02 1983-08-02

Publications (1)

Publication Number Publication Date
GR80020B true GR80020B (en) 1984-12-11

Family

ID=24068794

Family Applications (1)

Application Number Title Priority Date Filing Date
GR80020A GR80020B (en) 1983-08-02 1984-08-02 Steroids useful as anti-cancer,anti-obesity,anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents

Country Status (10)

Country Link
EP (2) EP0423842A3 (el)
JP (1) JPS6069096A (el)
AU (1) AU582122B2 (el)
CA (1) CA1314870C (el)
DE (1) DE3485647D1 (el)
DK (1) DK375384A (el)
ES (1) ES8706717A1 (el)
GR (1) GR80020B (el)
IE (1) IE72193B1 (el)
IL (1) IL72566A (el)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714481A (en) * 1983-08-02 1998-02-03 Research Corporation Technologies, Inc. Derivatives of 5-androsten-17 ones and 5-androstan-17-ones
US5804576A (en) * 1983-08-02 1998-09-08 Research Corporation Technologies, Inc. Derivatives of 5-androsten-17-ones and 5-androstan-17-ones
US5157031A (en) * 1983-08-02 1992-10-20 Research Corporation Technologies, Inc. Method for prophylaxis of obesity
US5656621A (en) * 1983-08-02 1997-08-12 Research Corporation Tech., Inc. Steroids useful as anti-cancer and anti-obesity agents
AU598201B2 (en) * 1985-08-02 1990-06-21 Research Corporation Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents
NO173278C (no) * 1986-05-21 1993-12-01 Research Corp Analogifremgangsm}te for fremstilling av terapeutisk aktive 5-androsten-17-on-derivater
NL194728C (nl) * 1987-04-16 2003-01-07 Hollis Eden Pharmaceuticals Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan.
JPS63267722A (ja) * 1987-04-27 1988-11-04 Daiichi Yakuhin Sangyo Kk 抗肥満症剤
US4897390A (en) * 1987-07-21 1990-01-30 Ruhe Rodney C Novel anti-obesity compounds and method of use
JPS6440428A (en) * 1987-08-07 1989-02-10 Daiichi Yakuhin Sangyo Kk Antihyperlipemia
US5028631A (en) * 1987-11-25 1991-07-02 Schwartz Arthur G Homoandrostan-17-one and homoandrosten-17-ones
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US5001119A (en) * 1987-11-25 1991-03-19 Schwartz Arthur G 16-substituted androstanes and 16-substituted androstenes
CA2066716A1 (en) * 1989-09-25 1991-03-26 Raymond A. Daynes Use of steroid hormones in compositions for inducing t cell lymphokine production
US5919465A (en) * 1989-09-25 1999-07-06 University Of Utah Research Foundation Methods for augmenting immunological responses through the administration of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S)
DK0547151T3 (da) * 1990-08-29 2003-03-17 Humanetics Corp Behandlingsmåde til fremme af vægttab under anvendelse af et substitueret delta-5-androsten
US5585371A (en) * 1990-08-29 1996-12-17 Humanetics Corporation Treatment of immune system with Δ5-androstenes
US5506223A (en) * 1990-08-29 1996-04-09 Humanetics Corporation Δ5-androstenes useful for promoting weight maintenance or weight loss and treatment process
JPH0684398B2 (ja) * 1990-08-31 1994-10-26 雪印乳業株式会社 新規なアンドロステン誘導体及びそれを用いる６‐アルキルカルボニルオキシ‐１４α‐ヒドロキシ‐アンドロスト‐４，６‐ジエン‐３，１７‐ジオンの製造法
JP3862295B2 (ja) * 1993-09-30 2006-12-27 独立行政法人理化学研究所 抗肥満剤
US5736537A (en) * 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
EP1422234A3 (en) * 1999-03-23 2010-12-08 Harbor BioSciences, Inc. Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone
JP2002540119A (ja) * 1999-03-23 2002-11-26 ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド 免疫修飾ステロイドとくに１６α−ブロモエピアンドロステロンのヘミハイドレート
CA2669753C (en) 1999-09-30 2012-06-26 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
EP2566482A1 (en) * 2010-05-07 2013-03-13 Institut National de la Santé et de la Recherche Médicale Progesterone receptor antagonists and uses thereof
EP2999708B1 (en) * 2013-05-21 2018-08-22 Dr. Reddy's Laboratories Ltd. Processes for the preparation of dehydroepiandrosterone and its intermediates
EP3695841A3 (en) * 2013-07-01 2020-11-04 The Research Foundation for the State University of New York Ship inhibition to combat obesity
US10702538B2 (en) 2014-06-17 2020-07-07 The Research Foundation For The State University Of New York Ship inhibition to induce activation of natural killer cells
EP3805243B1 (en) * 2019-10-09 2023-11-15 Windtree Therapeutics, Inc. Androstane derivatives with activity as pure or predominantly pure stimulators of serca2a for the treatment of heart failure

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2833793A (en) * 1957-09-30 1958-05-06 Searle & Co 17-oxygenated derivatives of 5-androstene-1, 3-diol
US2911418A (en) * 1959-01-02 1959-11-03 Searle & Co 16-halo 17-oxygenated androst-5-en-3-ols and esters
FR1355505A (fr) * 1959-02-03 1964-03-20 Upjohn Co Procédé de préparation de 6-fluoro stéroïdes de la série de l'androstène
GB876009A (en) * 1959-11-26 1961-08-30 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US3148198A (en) * 1960-09-06 1964-09-08 Searle & Co 3, 17-bisoxygenated 16alpha, 16beta-difluoroandrostenes and process
US3018298A (en) * 1961-03-14 1962-01-23 Searle & Co 17-oxygenated 3alpha-halo-5alpha-androstan-2beta-ols and derivatives thereof
GB989503A (en) * 1962-08-29 1965-04-22 British Drug Houses Ltd 6,16-disubstituted androstenes and process for the preparation thereof
DE1239306B (de) * 1963-05-11 1967-04-27 Vismara Francesco Spa Verfahren zur Herstellung von Ketosteroiden, die in alpha-Stellung zur Ketogruppe eine gegebenenfalls substituierte Allylgruppe tragen
US3166578A (en) * 1963-11-12 1965-01-19 Searle & Co (optionally 17-alkylated) 17-oxygenated 5alpha-androst-2-en-4-ones and intermediatesthereto
BE666194A (el) * 1964-06-30
US3357888A (en) * 1965-04-07 1967-12-12 Upjohn Co 4, 7-dimethyl androstene derivatives
BE754111A (fr) * 1969-07-29 1971-01-29 Upjohn Co Nouveaux 7alpha- et 7beta-methyl-3alpha,5alpha- cycloandrostanes et composes analogues 19-nor et leur procede de preparation
JPS5031155B2 (el) * 1972-05-29 1975-10-07
US3976691A (en) * 1972-12-11 1976-08-24 E. I. Du Pont De Nemours And Company Dialkylaminosulfur trifluorides as fluorinating agents
GB1550343A (en) * 1975-07-16 1979-08-15 Gist Brocades Nv Androstane derivatives
DE2705917C3 (de) * 1977-02-09 1980-05-08 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 3 ß , 16 ß -Dihydroxy-5-androsten- 17-on durch mikrobiologische Hydrolyse
DE2757157C3 (de) * 1977-12-19 1980-10-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 16 a -alkylierten Steroiden
EP0014971B1 (de) * 1979-02-16 1982-06-16 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von 1-alpha-Hydroxydehydroepiandrosteron
IE53463B1 (en) * 1981-06-15 1988-11-23 Akzo Nv Mono-and bisquaternary ammonium derivatives of 2 beta,16 beta-d-amino-5 alpha-androstane derivatives and pharmaceutical preparations containing same

Also Published As

Publication number Publication date
IE841991L (en) 1985-02-02
DK375384A (da) 1985-02-03
ES8706717A1 (es) 1987-07-01
EP0133995B1 (en) 1992-04-15
DE3485647D1 (de) 1992-05-21
IL72566A0 (en) 1984-11-30
EP0423842A3 (en) 1991-08-07
AU3145684A (en) 1985-10-03
DK375384D0 (da) 1984-08-02
IE72193B1 (en) 1997-03-26
IL72566A (en) 1988-08-31
ES535643A0 (es) 1987-07-01
CA1314870C (en) 1993-03-23
AU582122B2 (en) 1989-03-16
EP0133995A3 (en) 1985-11-27
JPS6069096A (ja) 1985-04-19
EP0133995A2 (en) 1985-03-13
EP0423842A2 (en) 1991-04-24

Similar Documents

Publication Publication Date Title
GR80020B (en) Steroids useful as anti-cancer,anti-obesity,anti-hyperglycemic, anti-autoimmune and anti-hypercholesterolemic agents
AU562739B2 (en) 3 keto delta4,9,19-nor steroid derivatives
IL70933A (en) Modified polysaccharide materials,their preparation and their use as supports
DE3475261D1 (en) Folding chair
DE3474552D1 (en) Steroids
AU558204B2 (en) Suspender fastener
HK17590A (en) 1-pyrimidinyloxy-3-hetarylalkylamino-2-propanols,preparation,and uses
DE3666437D1 (en) Steroids useful as anti-cancer, anti-obesity, anti-hyperglycemic, anti-autoimmune and anti-hyper-cholesterolemic agents
DE3461380D1 (en) Aldosterone-antagonistic steroids
DE3469265D1 (en) Folding chair
DE3460405D1 (en) Lubricating-grease composition, its preparation and application
AU3195584A (en) Simultaneously triggering series scr:s
IE831887L (en) 14-amino steroids
GB2141923B (en) Folding chair
AU1113783A (en) Shear frame mounting
GB2155018B (en) 2x-cyano-4d,5x-epoxy-androstane -3,17-dione
AU559741B2 (en) Folding door suitable for shower screens
EP0175540A3 (en) 20-silyl ether steroids, and preparing 17-hydroxy-20-keto steroids
AU574404B2 (en) Adjustable strut component attaching means
AU1289883A (en) Curtain rail bracket
DE3463507D1 (en) Polycyclic bisamidines, process for their preparation and their use as chemotherapeutics
GB2158072B (en) 23,23-difluoro steroids
GB8916636D0 (en) Steroid ethers
AU2784984A (en) Improvements in and/or relating to blinds, screens and the like and in particular to methods of mounting the same and operating same
IE832179L (en) Pregnane derivatives